Our lead molecules effectivelyblocked histone H3 deacetylation in pancreatic cancer cells and upregulatedthe tumor suppressor HEXIM1 and proapoptotic p57, both markers of BET inhibition. Here, DNER is linked to pancreatic neoplasm.